Advertisement

Topics

Companies Related to "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer" [Most Relevant Company Matches] - Page: 20 RSS

17:47 EST 21st January 2019 | BioPortfolio

Here are the most relevant search results for "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Therapy With Bevacizumab Doxorubicin Cyclophosphamide Followed Docetaxel Capecitabine" Companies 476–500 of 1,100+

Possibly Relevant

OncoEthix

OncoEthix is a privately held biotechnology company that plans to develop a small portfolio of oncology drug candidates, ensuring a proper foundation for commercial success. The company’s lead product, OTX008, a synthetic small molecule targeted to galectin-1, entered Phase 1 clinical trial in the first quarter of 2012. OncoEthix was incorporated in 2007 and completed a Series A financing ...


EBI

EBI is a pioneering global leader in electro and biomechanical medicine and one of six strategic business units of Biomet, the fifth largest producer of orthopaedic products worldwide. EBI designs, develops, manufactures and markets products used primarily by orthopaedic medical specialists in both surgical and non-surgical therapy. We feature an unparalleled line of innovative electrical stimulat...

QIAGEN

QIAGEN is one of the world’s leading providers of innovative enabling technologies and products for separating and purifying nucleic acids (DNA and RNA). Since 1986, the Company has developed and marketed a broad range of proprietary products for academic and industrial markets, including life science research, genomics, gene-based drug discovery, nucleic acid-based molecular diagnostics, geneti...


Daxor

Daxor Corporation is an innovatove medical instrumentation and biotechnology companyDaxor designed and developed by the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's trie blood volume. We believe that the BVA-100 Blood volume Analyzer has the potential to transform therapy in a broad range iof surgical and medical c...

Celcuity Inc.

We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular activity dri...

UVLrx Therapeutics, Inc.

Based in Oldsmar, Florida, UVLrx Therapeutics is dedicated to evidence-based medicine in the field of light therapy and offers the first known intravenous, concurrent delivery of Ultraviolet-A (UVA), RED and GREEN light wavelengths. In addition to two Nobel Prizes and NASA-backed research, hundreds of international clinical trials have verified the health ...

KEW Group Inc.

KEW Group Inc. (KEW) is revolutionizing cancer care by empowering oncologists with access to genomic insights to design optimal, individualized treatment approaches for patients. KEW Group’s comprehensive set of products and solutions are designed to provide clarity above the complexity of genome-guided, personalized cancer therapy, arming oncologists...

HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the development of innovative technologies and quality products. Its HeartSine samaritan PAD is a sophisticated, lightweight automated external defibrillator designed for rescuers of all skill levels and is idea...

Insight Psychological Centers

Treating eating disorders, weight management and general psychological issues, Insight delivers awareness and recovery seven days per week. Managed by Northwestern University adjunct faculty members Drs. Jenny Conviser and Susan McClanahan, Insight is a team of credentialed psychologists, psychiatrists and other clinicians providing individual, family and group therapy to Chicago area communities...

SIGVARIS

SIGVARIS® North America is part of an internationally active medical device group headquartered in Winterthur, Switzerland that focuses on the development, production and distribution of medical compression garments, including hosiery and socks. With distribution in more than 50 countries on six continents, SIGVARIS is recognized as a global industry le...

CureFAKtor Pharmaceuticals, LLC

CureFAKtor Pharmaceuticals is a biopharmaceutical company focused on the research and development of Focal Adhesion Kinase therapies to prevent or treat cancer. CureFAKtor's investigational and combination therapy products target pancreatic, breast, colon, melanoma, lung and brain oncology disorders. CureFAKtor research is conducted at the Roswell Park Cancer Institute. Additional information abou...

PhotoThera, Inc.

PhotoThera, Inc. (www.photothera.com), located in Carlsbad, California, is developing transcranial laser therapy (TLT) for the treatment of acute ischemic stroke and other neurological diseases and disorders. According to the American Stroke Association, stroke is the third leading cause of death in the United States with approximately 700,000 strokes annually. Ischemic stroke, which accounts fo...

Cerenis Therapeutics SA

Cerenis Therapeutics is a pharmaceutical company focused on the discovery, development and commercialization of breakthrough HDL therapies for the treatment of cardiovascular and metabolic diseases. Based on pioneering research conducted by Cerenis' team of world leaders in HDL therapy, the company is pursuing a range of HDL product candidates that are pos...

Biolectron Inc- EBI

EBI is a pioneering global leader in electro and biomechanical medicine and one of six strategic business units of Biomet, the fifth largest producer of orthopaedic products worldwide. EBI designs, develops, manufactures and markets products used primarily by orthopaedic medical specialists in both surgical and non-surgical therapy. EBI feature an unparalleled line of innovative electrical stimula...

North Coast Medical, Inc.

For forty years, North Coast Medical, Inc., has manufactured, supplied and distributed a broad range of industry-leading product lines across a continuum of rehabilitation medical care. A leader in Occupational, Physical and Hand Therapy medical markets, North Coast services the needs of in-patient/out-patient hospitals, skilled nursing facilities, clinics...

Maxim Healthcare Services

Founded in 2001, Reflectx Staffing a division of Maxim Healthcare Services is a unique staffing company that exclusively provides rehabilitation therapy professionals. Recognized in 2007 by Entrepreneur Magazine's "Hot 500" fastest growing small businesses, Reflectx provides travel, per diem and direct placement Physical and, Occupational Therapists, and Speech-Language Pathologists to healthcare ...

joimax®, Inc.

Founded in Karlsruhe, Germany, in 2001, joimax® is the leading developer and marketer of complete systems for endoscopic minimally invasive spinal surgery. With TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression procedures, MultiZYTE® (for facet and sacroiliac joint therapy) or with EndoLIF® and ...

Yuva Medical Spa

Yuva Medical Spa provides a tranquil ambiance that strives to relieve stress and tension through soothing treatments for body, mind, and spirit. With an ongoing list of treatments and procedures, Yuva offers individualized programs designed by experts including exercise specialists and nutritionists, as well as massage therapists. At Yuva, the goal is to i...

Acticor Biotech

Acticor Biotech is a clinical stage biotechnology company, spin-off of INSERM, dedicated to developing an innovative treatment in the therapy of acute thrombotic diseases, including ischemic stroke and pulmonary embolism. Acticor Biotech is built upon the expertise and the results of researches conducted by, the founders: Dr. Martine Jandrot-Perrus at INSE...

Epilepsy Therapy Project

Epilepsy is a neurological disorder that affects approximately three million Americans and 50 million people worldwide. Epilepsy has many potential causes, but often no definitive cause is found. Approximately 200,000 new cases of epilepsy will be diagnosed in the United States this year affecting as many people as breast cancer. The need for more effective therapies is acutely felt by the mil...

Casamba, LLC

From scheduling to documentation at the point of care, EMR to analytics, payroll to billing and collections, Casamba's software and services maximize the business and clinical potential of providers across the post-acute continuum of care. Casamba solutions support over 1200 companies nationwide in contract therapy, skilled nursing facility, outpatient cli...

Walgreens and Express Scripts

Express Scripts manages more than a billion prescriptions each year for tens of millions of people. On behalf of our clients, we make the use of prescription drugs safer and more affordable. We innovate to enhance patient care, reduce pharmacy-related waste and increase therapy adherence. Building on a strong clinical foundation, we apply our understanding...

Savient Pharmaceuticals

Savient Pharmaceuticals, Inc. is a specialty pharmaceuticals company engaged in developing, manufacturing, and marketing pharmaceutical products that address unmet medical needs in both niche and broader markets. The company has initiated Phase 3 trials for its flagship product Puricase® (PEG-uricase) , for treatment-failure gout. Savient currently markets Oxandrin® (oxandrolone, USP) in the U.S...

Hemodynamic Therapeutics, Inc.

HTI was formed in 2004 as a majority-owned portfolio company of Cato BioVentures. Through its strategic development relationship with Cato BioVentures and its contract research and development affiliate, Cato Research Ltd., HTI executed its Phase 2 development program for HTI-101, a novel small molecule combination therapy for obesity-related hypertension (ORH), one of the world's fastest growing ...

OPTIME Therapeutics Incorporated

OPTIME Therapeutics is a biopharmaceutical company developing novel topical products based on new drug delivery systems through the innovative use of liposomes – naturally occurring microscopic spheres that can function as the carriers for therapeutic agents into the human body. OPTIME’s topical drug delivery technology provides significantly greater effectiveness and safety for many types of...


More From BioPortfolio on "Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks